The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Subscribe To Our Newsletter & Stay Updated
